Related by context. All words. (Click for frequent words.) 76 Gastrointestinal Cancers Symposium 75 Clinical Oncology Annual Meeting 74 ASH Annual Meeting 74 Digestive Disease Week DDW 74 Genitourinary Cancers Symposium 73 Digestive Disease Week 73 AACR #st Annual Meeting 73 ICAAC 73 Clinical Oncology ASCO Annual 72 AACR NCI EORTC 72 AHA Scientific Sessions 72 SABCS 71 nd Annual Meeting 71 Prostate Cancer Symposium 70 Hematology Annual Meeting 70 Annual Scientific Sessions 70 ADA Scientific Sessions 70 Hematology ASH Annual Meeting 70 ASTRO Annual Meeting 70 ASCO Genitourinary Cancers Symposium 70 ASCO GI 70 Digestive Diseases Week 69 AACR San Antonio 69 Society CTOS 69 AASLD 68 ECTRIMS 68 AUA Annual Meeting 68 Endocrine Society Annual Meeting 68 EORTC NCI AACR Symposium 68 AAN Annual Meeting 68 AACR #nd Annual Meeting 67 Connective Tissue Oncology 67 #th Annual Interscience 67 Clinical Oncology ASCO 67 Transcatheter Cardiovascular Therapeutics TCT 67 st Annual Meeting 67 ACR ARHP 67 Pediatric Academic Societies 67 EORTC NCI AACR 67 ICAAC IDSA 67 AACR Meeting 67 #st Annual Meeting 66 ISPOR 66 ASCO 66 Antimicrobial Agents 66 Pediatric Academic Societies PAS 66 #nd Annual Meeting 66 Scientific Sessions 66 UEGW 66 #nd EORTC NCI 66 CROI 66 Molecular Targets 66 Neurology Annual Meeting 66 BIOCOM Investor Conference 66 Late Breaker 65 Therapeutics TCT scientific 65 Biological Therapy 65 Alzheimer Disease ICAD 65 Rheumatology ACR Annual 65 Breast Cancer Symposium SABCS 65 annual Transcatheter Cardiovascular 65 International Myeloma Workshop 65 AACR Annual Meeting 65 Opportunistic Infections CROI 65 ASCO Breast Cancer 65 Chemotherapy ICAAC 65 www.asco.org 65 Cancers Symposium 65 Breast Cancer Symposium 65 SAEM Annual Meeting 64 CTRC AACR San Antonio 64 Chicago Multidisciplinary Symposium 64 Gastroenterology ACG Annual 64 #th Interscience Conference 64 Transcatheter Cardiovascular Therapeutics 64 ESMO 64 CLEO QELS 64 Nephrology Renal Week 64 AAO HNSF Annual Meeting 64 Hematology Meeting 64 Endocrine Society ENDO 63 AAAS Annual Meeting 63 Radiation Oncology ASTRO 63 ASCO abstract 63 Therapeutics TCT 63 Hematology ASH 63 Rheumatology Annual 63 Annual Transcatheter Cardiovascular 63 ASCO Gastrointestinal Cancers Symposium 63 EuroPCR 63 ECCMID 63 Symposium SABCS 63 GASTRO 63 ASGT 63 VEITHsymposium 63 Medical Oncology ESMO 63 BIO InvestorForum 62 Molecular Medicine Tri 62 ® DDW 62 Oncology ASTRO 62 Poster Discussion 62 ECCO ESMO 62 EORTC NCI 62 Cancer iSBTc 62 ORAL Sync 62 Arteriosclerosis Thrombosis 62 ERA EDTA 62 Infectious Diseases ECCMID 62 Scientific Session 62 DDW ® 62 HCV SPRINT 62 ASCO GU 62 Endocrine Society #nd 62 Neurology AAN 62 AACR 62 ongoing Phase 1b 62 AABB Annual Meeting 62 USpella 61 League Against Rheumatism 61 ACC.# 61 Annual ICAAC 61 AACR Frontiers 61 ARVO 61 Related Disorders ICAD 61 Poster Session 61 Heart Failure Society 61 www.aacr.org 61 Vascular Annual Meeting 61 ASBMR 61 AACR symposium 61 Pediatric Academic Society 61 Poster Presentations 61 NSTI Nanotech 61 Clinical Trial Results 61 DIA Annual Meeting 61 Canaccord Adams Hepatitis C 61 & OTO EXPO 61 AASLD Meeting 60 th Interscience Conference 60 Malignant Lymphoma 60 EASL 60 www.nejm.org 60 Poster Presentation 60 AACR IASLC Joint 60 Spine Arthroplasty Society 60 AAICAD 60 Clinical Oncology 60 European CanCer Organisation ECCO 60 Podium Presentation 60 Oral Presentation 60 Endocrine Society #st 60 ESTRO 60 Room #AB [002] 60 International Papillomavirus 60 American Thoracic Society 60 R roscovitine 60 Scientific Meeting 60 Therapeutic Radiology 60 PROSTVAC TM 60 ACR ARHP Annual 60 ASMS Conference 60 Keystone Symposia 59 entitled Synergistic 59 Randomized Phase 59 Phase 2a clinical 59 ENDEAVOR III 59 Oral Presentations 59 Clinical Oncologists 59 Atrial Fibrillation Symposium 59 Cambridge Healthtech Institute 59 Retroviruses 59 HIMSS# Interoperability Showcase 59 AIIM Expo 59 Hematology ASH Meeting 59 Cystic Fibrosis Conference NACFC 59 ABRF 59 AIR2 Trial 59 Interventional Radiology SIR 59 Rheumatology Annual Meeting 59 Liver Meeting 59 Cardiology Scientific Sessions 59 REITWeek 59 iSBTc 59 Clinical Trials Update 59 Combination REOLYSIN R 59 AAAAI Annual Meeting 59 BioProcess International 59 AACR NCI EORTC Molecular 59 Breaking Clinical Trials 58 Midyear Clinical Meeting 58 SNM Annual Meeting 58 Neoplasia 58 EVEREST II 58 San Antonio Breast Cancer 58 Gynecologic Cancer Society 58 EASD 58 SUCCEED trial 58 NAREIT Investor Forum 58 ECNP 58 Clinical Microbiology 58 Vascular Biology ATVB 58 American Roentgen Ray 58 HORIZONS AMI trial 58 Oral Fingolimod 58 BRIM3 58 & Immunology AAAAI 58 dose escalation clinical 58 ACUITY trial 58 IPC APEX Expo 58 LymphoStat B 58 Phase III VISTA 58 Clinical Virology Symposium 58 CRLX# 58 Immunology Annual Meeting 58 Printable slides 58 American Psychosomatic Society 58 Phase Ib study 58 NAREIT REITWeek 58 #rd Annual CTRC 58 randomized discontinuation trial 58 Opportunistic Infections 58 Phase III ALLEGRO 58 BiTE R 58 TG MV 58 Microbiology ASM 58 Cardiostim 58 SPIE Photonics West 58 Gene Therapy ASGT 58 Long Awaited Reality 57 Phacilitate Vaccine Forum 57 Therapeutics Roundtable 57 Gastrointestinal Cancer 57 recurrent glioma 57 Phase III AFFIRM 57 Interscience Conference 57 ENESTnd 57 randomized controlled Phase 57 GITA Annual 57 Lung Transplantation 57 Abstract Number 57 Brentuximab Vedotin SGN 57 BRIM2 57 Interventions SCAI 57 Experimental Biology EB 57 journal Antimicrobial Agents 57 Selective Cardiac Myosin 57 Arch Surg 57 Zenvia Phase III 57 ARVO Annual Meeting 57 Neck Surgery Foundation 57 America HFSA 57 Fifth Decennial International 57 Scientific Poster Session 57 HIMSS Annual 57 Ovarian PLCO Cancer 57 Annual Meeting 57 perifosine KRX 57 PITTCON 57 NEJM.org 57 Clinical Antipsychotic Trials 57 BCIRG 57 multicenter Phase 57 Advanced Neuroendocrine Tumors 57 RECORD1 57 Therapeutic Targets 57 Therapeutic Radiation 57 viral kinetic 57 Cell Biology ASCB 57 Solid Tumors 57 HFSA Annual 57 Endovascular Therapy ISET 57 SMTAI 57 HIMSS# 57 RSNA 57 Breast Surgeons 57 www.annals.org 57 Advanced Renal Cell 57 Metastatic Melanoma 57 GTCbio 57 number NCT# ClinicalTrials.gov 57 ENDEAVOR IV 57 RTOG 57 Phase Ib II 57 oral ridaforolimus 56 Molecular Therapy 56 Pharmaceutical Scientists AAPS 56 Phase Ib clinical 56 PEGylated interferon beta 1a 56 www.hematology.org 56 EORTC 56 American Urological Association 56 Annual HIMSS 56 Malignant Mesothelioma 56 Glufosfamide 56 HORIZONS AMI 56 Windhover Therapeutic Area 56 oral FTY# 56 website www.asco.org 56 Traficet EN 56 Neurology AAN Annual Meeting 56 Liver Diseases AASLD 56 ABCSG 56 Cardiovascular Renal Physiology 56 PAINWeek 56 Selective Cardiac Myosin Activator 56 Cancer Immunotherapy 56 COPIC Energy 56 FOLOTYN ® 56 HCV Protease Inhibitor 56 PreCISe 56 EOquin TM 56 Systemic Sclerosis 56 Clinical Oncology Gastrointestinal Cancers 56 ERA D2C Convention 56 Hematology 56 Oral Insulin Capsule 56 Phase 2a Study 56 ISHLT 56 CAMMS# 56 Biodetection Technologies 56 ENDO 56 CTAP# Capsules 56 Biotech Showcase 56 Capsule Endoscopy 56 Clinical Therapeutics 56 Abstracts 56 AAPS Annual Meeting 56 Anticancer Drugs 56 Gynecological Cancer 56 NO# [002] 56 KRN# 56 LabAutomation 56 Canaccord Genuity Musculoskeletal 56 Edge STudy 56 Tanespimycin 56 PROactive Study 56 Phase III psoriasis 56 International Neuropsychological Society 56 MERLIN TIMI 56 SAWC WHS 56 www.thelancet.com 56 teriflunomide 56 Prostate AdenoCarcinoma Treatment 56 CALGB # [002] 56 TXPO 56 Sybase TechWave 56 ASCRS 56 Lysosomal Disease Network 56 CALGB 56 trastuzumab DM1 T DM1 56 registrational Phase 56 Randomized Phase III 56 Cinapsys Microcap Conference 56 journal Resuscitation 56 EFNS 56 CUSTOM II 56 Recurrent Chest Wall 56 Anesthesiologists ASA Annual Meeting 56 Clinical Oncology JCO 56 Molecular Cancer 56 VEITHsymposium ™ 56 Annual Interscience Conference 56 PODi AppForum 56 CCX# 56 Investor Luncheon 55 Preclinical Data 55 Liver EASL 55 Prospective Multicenter 55 Randomized Phase II 55 Cardiovascular Horizons 55 LUMINATE 55 XL# XL# XL# 55 Hedgehog Pathway Inhibitor 55 AAGL 55 CLARITY study 55 Phase 1b trial 55 II Clinical Trial 55 DDW 55 Breast Surgeons ASBS 55 multicenter clinical 55 RGB # 55 NAREIT Investor 55 NASDAQ CXSP announced 55 IASLC 55 multicenter trials 55 Hematological Malignancies 55 Initiated Phase 55 Needham Growth Conference 55 CLARITY TIMI 55 PROVENGE sipuleucel T 55 Phase 2a trial 55 Canaccord Adams Musculoskeletal 55 PERSEUS 55 Vaccine Immunology 55 PROTECT AF 55 phase IIa clinical 55 NASDAQ CYTK announced 55 ASM Biodefense 55 Peer Reviewed Journal 55 assessing T DM1 55 SID Display Week 55 Diabetologia 55 TASKi2 55 LD MICRO Conference 55 MEND CABG 55 AAPM 55 Archived webcasts 55 Phase #/#a trial 55 Hsp# Inhibitor 55 BR.# 55 PROTECT II 55 MelaFind pivotal 55 Pharmacoeconomics 55 Refractory Angina 55 EXPAREL ™ 55 Cardiovascular Interventions 55 Inflammatory Bowel Diseases 55 HCV RESPOND 2 55 placebo controlled clinical 55 EURIDIS 55 Clinical Oncology ASCO Gastrointestinal 55 EULAR 55 Dose Escalation 55 Therapeutic Advances 55 LD Micro 55 Pooled Analysis 55 orally inhaled migraine 55 Developmental Therapeutics Immunotherapy 55 NCVH 55 Phase III ThermoDox 55 Solorel TM 55 NCIC CTG 55 Neuro Oncology SNO 55 MERIT ES 55 SNW Spring 55 Abstract # 55 AHIMA Convention 55 International Microwave Symposium 55 Intervention Effectiveness 55 GTCbio 3rd 55 Drugs Affecting Lipid 55 ASLA Annual Meeting 55 Semafore Pharmaceuticals 55 Targeted Therapies 55 AVADO 55 HIMSS Healthcare 55 Multicenter 55 Sipuleucel T 55 fosbretabulin 55 Environ Health Perspect 55 Electro Optics CLEO 55 AAEP Convention 55 SIMposium 55 evaluating tivozanib 55 Inc. Nasdaq OPTR 55 LUX Lung 55 Gynecologic Investigation 55 Neuropsychopharmacology 55 phase IIa 55 EULAR Annual 55 MEK Inhibitor 55 CHEST 55 RTECC 55 Phase 2b Clinical Trial 55 Plastic Surgeons ASPS Plastic 55 Phase #b/#a clinical 55 journal Oncogene 55 evaluating mipomersen 55 Clinical Chemistry AACC 55 Cardiology ESC Congress 55 Oligonucleotide Therapeutics Society 55 ThermoDox ® clinical 55 Arch Intern Med 55 Relapsed Multiple Myeloma 55 ganetespib 55 EACTS 55 ZYBRESTAT TM 55 pharmacokinetic PK 55 Am J Epidemiol 55 America RSNA 54 rALLy clinical trial 54 AACR EORTC NCI 54 depsipeptide 54 http:/www.vical.com 54 Uterine Fibroid Embolization 54 BioPharm America 54 SPIRIT IV 54 Antibody Therapeutics 54 J Clin Oncol 54 EFORT Congress 54 Human Genetics ASHG 54 Quinamed 54 Elagolix 54 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 54 Cardiology ACC 54 Preclinical Study 54 IMPROVE HF 54 HDL Selective Delipidation 54 Retrovirus Conference 54 Coordinate Metrology Systems 54 abstracts summarizing 54 SA FC# 54 ExTRACT TIMI 54 BioDevice Partnering 54 Cardiovascular Therapeutics 54 NEVO RES 54 ToGA 54 Interoperability Showcase 54 Vaccine Adjuvant 54 ISMB 54 Biodefense Vaccines 54 Thermo Scientific booth 54 Medicine SIIM 54 Bright Lights Conference 54 Phase 1b 54 AVERROES 54 System Pharmacists ASHP 54 Trodusquemine MSI 54 Phase III ADT 54 Telbivudine 54 Global Healthcare Unplugged 54 SCCHN 54 Hypertension ASH 54 phase IIb 54 Clinicaltrials.gov 54 CUSTOM III 54 www.snwusa.com 54 ACM SIGCOMM 54 Endourology 54 Nasdaq ENZN 54 CIRSE 54 Carfilzomib 54 VoiceCon Spring 54 AIDS Vaccine 54 article #.#/NEJMoa# 54 CardioBip 54 AGBT 54 Canaccord Genuity Healthy Living 54 Photovoltaics Summit 54 NASDAQ SLXP today 54 EGS# 54 phase IIb study 54 Randomized Double Blind 54 Arch Neurol 54 PEG SN# 54 Phase 2b trial 54 randomized Phase III 54 BIO VentureForum East 54 Genome Biology 54 IEEE GLOBECOM 54 sorafenib tablets 54 Radiation Therapy Oncology 54 Thoracic Oncology 54 Inc. Nasdaq AMLN 54 liposome injection 54 Postgraduate Course 54 multicenter prospective 54 INCB# [001] 54 BOLDER II 54 Phase 2a Trial 54 PIX# [002] 54 EUROGIN 54 Canaccord Genuity Growth 54 PROSTASCINT R 54 pertuzumab 54 OTO EXPO 54 rALLy trial 54 Science Translational Medicine 54 Clinical Dermatology 54 alvespimycin 54 Nordic ACTI 54 Topline Results 54 enzastaurin 54 Delcath Phase III 54 Immunology ACAAI 54 Phase IIb Clinical Trial 54 axitinib 54 Antiviral Therapy 54 novel VDA molecule 54 NCCTG N# 54 journal Arteriosclerosis Thrombosis 54 ID NCT# 54 Lehman Brothers T4 54 Advanced Solid Tumors 54 RESTORE CLI 54 AACC Annual Meeting 54 Coronary Revascularization 54 Dr. Yatscoff 54 SCAI Annual 54 Urology EAU 54 Pivotal Clinical Trial 54 sipuleucel T 54 multicenter randomized Phase 54 Gaylord Palms Hotel 53 HeFT 53 Sapacitabine 53 Applied Spectroscopy 53 Mass Spectrometry ASMS 53 www.vical.com 53 INSPIRE Trial Phase III 53 Minimally Invasive Gynecology 53 Storer Auditorium 53 Experimental Biology Annual Meeting 53 Randomized Double blind 53 Phase IIB 53 Maternal Fetal Medicine SMFM 53 phase IIIb 53 Therapeutic Radiation Oncology 53 ALA Midwinter Meeting 53 Epilepsia 53 Hormone Refractory Prostate Cancer 53 Novel Therapeutics 53 Research IADR 53 ECNP Congress 53 PRNewswire FirstCall Tercica 53 Blinatumomab 53 IEEE MTT S 53 CYT# potent vascular disrupting 53 antibody blinatumomab MT#/MEDI-# 53 CIBMTR 53 BIO Windhover 53 Craig Hallum Institutional Investor 53 AA Amyloidosis 53 Needham Biotechnology 53 neoadjuvant treatment 53 Neuro Oncology 53 Medicine AAPM 53 ASCO Prostate Cancer 53 NCCN Clinical Practice 53 Outcomes Research ISPOR 53 NCCTG 53 DoDIIS Worldwide Conference 53 Acquired Immune Deficiency Syndromes 53 ON #.Na 53 Keynote Session 53 AOSSM 53 Clinical Practice Guideline 53 DigitalFocus 53 PERSEUS clinical program 53 Phase 2a 53 delafloxacin 53 AACR Symposium 53 BARI 2D 53 AeA Classic 53 Thomas Weisel Partners Tech# 53 Ann Rheum Dis 53 TACI Ig 53 peer reviewed journal Annals 53 Screening Trial 53 LymphoStat B TM 53 Planet xMAP Europe 53 Castration Resistant Prostate Cancer 53 ASGCT 53 Cachexia 53 Outpatient Setting 53 Molecular Psychiatry 53 ABA TECHSHOW 53 www.celsion.com 53 ISSWSH 53 PRNewswire FirstCall Amylin Pharmaceuticals 53 Ophthalmology ARVO 53 PROactive study 53 EMBLEM TM 53 Natalizumab 53 Tesetaxel 53 BioContact Quebec 53 BMC Musculoskeletal Disorders 53 Proc Am Soc 53 ESCRS 53 SWOG 53 LabAutomation# 53 PackExpo 53 EmTech @ MIT 53 Phase III Clinical Trial 53 REG2 53 transthyretin TTR mediated amyloidosis 53 ELACYT 53 Product Monograph 53 HCV Genotype 53 YONDELIS 53 Association EHA 53 NanoCommerce 53 HIV Pathogenesis Treatment 53 http:/jasn.asnjournals.org/ 53 USENIX Security 53 multicenter Phase II 53 Cardiovascular Anesthesiologists 53 forodesine 53 Nymox NX 53 Dr. Pingpank 53 Aplidin R 53 fidaxomicin Phase 3 53 Lancet Neurology 53 Clinical Trials 53 CIMZIA TM certolizumab pegol 53 ClinicalTrials.gov 53 Am J Pathol 53 APPRAISE 53 mg administered orally 53 #:# -# [004] 53 Arch Pediatr Adolesc Med 53 JPMorgan SMid Cap 53 ASHG 53 abstracts 53 HIMSS# Annual Conference 53 EuroIntervention 53 VIVUS Qnexa 53 Phase 2b RESTORE CLI 53 Acute Heart Failure 53 Dr. Siegall 53 CAPRISA 53 phase IIb clinical 53 Announces Poster Presentations 53 Antiviral Activity 53 Obesity Reviews 53 Catheterization 53 Hepatocellular Carcinoma 53 Clinical Trial Data 53 NeuroImage 53 Refractive Surgery ASCRS 53 Obes Res 53 www.micromet inc.com 53 Echocardiography ASE 53 NeuroReport 53 RE LY 53 preclinical efficacy 53 Cancer Therapeutics 53 ORMD 53 Venereology EADV 53 Phase Ib Clinical Trial 53 stage hypoxia activated 53 Amrubicin 53 Diabetic Macular Edema 53 Neuropathic Pain 53 Endovascular Valve Edge 53 journal Gene Therapy 53 CTI Nasdaq 53 Archexin 53 http:/www.ncbi.nlm.nih.gov/pubmed/# 53 Gastroenterology ACG 53 Cardiovascular Disease Epidemiology 53 BiOS 53 ILLUMINATE 53 Bipolar Disorders 53 including eniluracil ADH 53 SAGES 53 Network HVTN 53 phase 2a 53 Cancer Therapeutic 53 NEUVENGE 53 CODiE Awards Gala 53 Gastrointestinal Oncology 53 Aggressive Reduction 53 Equine Practitioners Convention 53 Developmental Therapeutics 53 SCTE Cable Tec EXPO 53 Connectathon 53 Lancet Oncology 53 Gynecol Oncol 53 ANN INTERN MED 53 Urocortin 2 53 Glucosamine Chondroitin Arthritis 53 evaluating REVLIMID 53 PRECISE 53 Anesthesiologists Annual Meeting 53 Scrip Awards 53 EchoCRT 53 http:/www.genmab.com 53 abstr 53 Windhover Conferences 53 Group RTOG 53 Aggressive Drug Evaluation 53 Acute Myocardial Infarction 53 clinical pharmacology studies 53 ICAD 53 prospective observational 53 Biophysical Society 53 ROCKET AF 52 OneMedPlace Finance Forum 52 In3 East 52 Novalis Circle 52 elotuzumab 52 Retina Specialists ASRS 52 HIMSS Interoperability Showcase 52 CR# vcMMAE 52 Double Blind Placebo 52 EGEN 52 Therapeutic Approaches 52 multicenter Phase III 52 EMBASE 52 Diabetes EASD 52 #:#-# [033] 52 compound AEZS 52 Inflammatory Arthritis 52 DIA EuroMeeting 52 SYNTAX trial 52 Circulation Cardiovascular Genetics 52 Phase #/#a 52 Hodgkin lymphoma HL 52 lexidronam injection 52 Br J Cancer 52 journal Lancet Neurology 52 Tyrosine Kinase Inhibitor 52 APOPTONE 52 ZYBRESTAT fosbretabulin 52 Respiratory Viruses 52 ISPE Annual Meeting 52 BioCentury Future Leaders 52 Drug Formulation 52 Completes Patient Enrollment 52 HCV polymerase inhibitors 52 Best Practices Awards Banquet 52 tanespimycin 52 Human Brain Mapping 52 ARRS Annual Meeting 52 Hyatt Regency O'Hare 52 Parallels Summit 52 Oral Session 52 Belimumab 52 HuMax EGFr 52 ZFP Therapeutic 52 CoreNet Global Summit 52 Schizophrenia Bulletin 52 Natixis Bleichroeder Hidden Gems 52 Acute Decompensated Heart Failure 52 IHE Connectathon 52 ZYBRESTAT 52 ALN TTR 52 Chronic Lymphocytic Leukemia 52 Genta Incorporated OTCBB GETA 52 Stem Cell Research ISSCR 52 BHIVA 52 Azedra 52 BIO# 52 FDA Oncologic Drugs 52 ASN Renal Week 52 ThinkEquity Partners Growth 52 Online Educa Berlin 52 pharmacokinetic PK study 52 Related Viruses 52 In3 EUROPE 52 Suppl. 52 Neurological Surgeons Annual Meeting 52 Mineral Research ASBMR 52 Plenary Session 52 seliciclib CYC# 52 phase Ib 52 www.pranabio.com 52 Antimicrobial Chemotherapy 52 Completes Patient Enrolment 52 BiovaxID Phase 52 Phase IIb Trial 52 Novel Approaches 52 SYMMETRY trial 52 Romidepsin 52 Controlled Release 52 Ann Intern Med 52 Molecular Origins 52 Intervention Trial GAIT 52 comparing alemtuzumab 52 Safinamide 52 vidofludimus 52 Pivotal Phase 52 HER2 positive metastatic breast 52 neratinib 52 HIMSS# Annual 52 cabozantinib 52 Relapsing Multiple Sclerosis 52 EADV 52 Randomized Clinical Trials 52 Cancer Therapies 52 metastatic CRC 52 Interventional Radiology 52 AIIM Exposition 52 RSNA Annual Meeting 52 Haemostasis ISTH 52 SCTE Cable Tec Expo 52 PRNewswire FirstCall Genaera 52 DASISION 52 journal PLoS Pathogens 52 ONTARGET 52 MT# MEDI 52 Fuel Cell Seminar 52 #:# -# [006] 52 Randomized Controlled 52 relapsed refractory multiple myeloma 52 non nucleoside HCV 52 ZACTIMA 52 SYN# 52 substudy 52 BioFinance 52 www.telik.com 52 PRNewswire FirstCall Genta Incorporated 52 lintuzumab 52 IMS# 52 PSMA ADC 52 MASCC 52 Active Biotech NASDAQ OMX 52 Nasdaq REGN 52 Immunotherapeutic 52 PXD# 52 ICON7 52 MOZOBIL 52 Initiate Phase 52 bazedoxifene conjugated estrogens 52 Biomacromolecules 52 Phase 2b study 52 viral kinetics 52 PROLARIS 52 Aflibercept 52 Breaking Clinical Trial 52 JACC Cardiovascular Interventions 52 SPIE Defense 52 CJASN 52 CRMD# 52 Clin Infect Dis 52 Nasdaq GNTA 52 Hand ASSH 52 Select Biosciences 52 Ambrisentan 52 Phase 2b Study 52 subanalysis 52 Tumor Biology 52 Tumor Microenvironment 52 http:/www.compellent.com/investors 52 C# BioVentures 52 HCV NS5B polymerase 52 AeA Classic Financial 52 Optical Fiber Communications 52 XL# SAR# 52 refractory multiple myeloma 52 See CLINICAL PHARMACOLOGY 52 Adobe Acrobat format 52 Rigel R# 52 Acute Ischemic Stroke 52 journal Nature Physics 52 Biomarker Study 52 DAPT Study 52 PLoS Pathogens 52 recurrent malignant glioma 52 Medtech Insight Investment 52 Nasdaq DVAX 52 Dr. Agarwala 52 Influenza Vaccines 52 SPIRIT FIRST 52 Canaccord Adams Healthy Living 52 Nasdaq CYCC Nasdaq CYCCP 52 SEMI NanoForum 52 ISTH 52 PloS ONE 52 PEARL HF 52 randomized Phase IIb 52 www.depomedinc.com 52 metastatic castration resistant 52 Study Evaluating 52 CYT# 52 Cervical Pathology 52 CED Biotech 52 Pivotal Phase III 52 SAWC 52 Pirfenidone 52 Investigational Drugs 52 Chronic Hepatitis C 52 OneMedForum 52 www.ClinicalTrials.gov 52 Pharmacoepidemiology 52 Antiviral Research 52 Brachytherapy Society 52 In3 WEST 52 Guanilib 51 Tesmilifene 51 dose escalation trial 51 HUPO 51 Pediatric Oncology Branch 51 Abstract Accepted 51 Deltek Insight 51 Genitourinary Cancer 51 Movement Disorder 51 Sangamo BioSciences Announces 51 Ozarelix 51 Symposium Seminar 51 ACS Chemical Biology 51 Upcoming Presentations 51 Clinical Cancer 51 Molecular Markers 51 brivaracetam 51 National Guideline Clearinghouse 51 Myelodysplastic Syndromes 51 Talabostat 51 Novel Small Molecule 51 Dendritic Cells 51 Endoscopic Surgeons SAGES 51 journal SLEEP 51 Medicinal Chemistry Letters 51 Phase III Clinical Trials 51 multicenter study 51 canbe accessed 51 Heart Assn 51 #.#/science.#